Since I can remember, I've been playing video games...
What Can Healthcare Learn From Wall Street?
Prior to 2004, my exposure to information technology in healthcare had been limited to selling an early version of the Oracle database management system to a few hospitals.
Meeting Spot Recap: TEPR 2007
The 23rd annual TEPR Conference & Exhibition took place May 19-23 in the Dallas Convention Center in Dallas, TX.
Bristol-Myers Squibb is a "leading provider of medicines to fight cancer, cardiovascular and infectious diseases" including HIV/AIDS "and serious mental illness."
ePrescribing: What to Look For
Research studies published in JAMA and by the Institute of Medicine demonstrate that prescription errors account for a staggering number of deaths and adverse drug reactions in the US.
Split Personalities: It Takes Two to Tango
MDNG spoke with Neal Goldman, MD, assistant professor, department of otolaryngology, Wake Forest University Baptist Medical Center, Winston-Salem, NC, to learn how he juggles practicing both...
5 Questions... with Gary Kennedy, President and Chief Executive Officer, RemedyMD
The beat on the people, devices and companies shaping healthcare.
And the Organ Goes to...
End-stage organ failure is a growing problem in the US, due in part to the fact that the number of available donor organs is lagging far behind the number of people (approximately 96,000...
Healthcare Tech Talent: Not Just a Plus, It's a Must!
Whether you're a medical student on the cusp of graduation, a physician who has been practicing medicine for years, or an up-and-coming healthcare information technology (IT) specialist, you...
20 Top Websites for Docs
The Internet is a seemingly endless source of medical information. With a couple of mouse clicks, we can easily access useful resources, such as specialty medical websites, PDA downloads, online...
Sotigalimab/Pembrolizumab Combo Continues to Show Clinical Activity in Frontline Melanoma
Dr. Halmos on Trastuzumab Deruxtecan in NSCLC
Dr. Kris on Immunotherapy in NSCLC Without Driver Mutations
Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.